3.0.0 985 2022-11-01T15:32:55Z 2022-11-01T15:32:55Z House HR 2019-02-05 116 [Congressional Record Volume 165, Number 22 (Tuesday, February 5, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. WELCH:H.R. 985.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18: The Congress shall havePower To . . . make all Laws which shall be necessary andproper for carrying into Execution the foregoing Powers, andall other Powers vested by this Constitution in theGovernment of the United States, or in any Department orOfficer thereof..[Page H1363]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2019-02-05T17:02:05Z 2019-02-05 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-02-05 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-02-05 Introduced in House IntroReferral 1000 9 Library of Congress W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT N M001180 Rep. McKinley, David B. [R-WV-1] David McKinley R WV B. 1 2019-02-05 True C001084 Rep. Cicilline, David N. [D-RI-1] David Cicilline D RI N. 1 2019-02-05 True C001090 Rep. Cartwright, Matt [D-PA-8] Matt Cartwright D PA 8 2019-03-11 False S001208 Rep. Slotkin, Elissa [D-MI-8] Elissa Slotkin D MI 8 2019-05-20 False Health Competition and antitrust Drug safety, medical device, and laboratory regulation Licensing and registrations Prescription drugs Health 00 2019-02-05 Introduced in House 2021-09-10T17:46:01Z Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019

This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.

]]> FAST Generics Act of 2019 Display Title FAST Generics Act of 2019 Short Title(s) as Introduced FAST Generics Act of 2019 Introduced in House IH Short Title(s) as Introduced Fair Access for Safe and Timely Generics Act of 2019 Introduced in House IH Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes. Introduced in House IH Introduced in House 2019-02-05T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr985ih/xml/BILLS-116hr985ih.xml 2019-02-05 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.